In KMT2A-rearranged acute leukemia, sensitization following curaxin and panobinostat treatment is mediated by increasing histone acetylation, decreasing MYC expression, and not by altered expression of target genes HOXA9 and MEIS1 [10]. This evidence concerns the gene MEIS1 and acute leukemia.